Evidence map›Paper›PMID 34128365›Full record

ReviewJournal of breast cancer2021

The Italian Association of Radiotherapy and Oncology Recommendation for Breast Tumor Recurrence: Grades of Recommendation, Assessment, Development and Evaluation Criteria.

Marta Bottero, Valentina Borzillo, Stefano Pergolizzi, Barbara Alicja Jereczek-Fossa, Edy Ippolito, Giovanni Piero Frezza, Lucio Fortunato, Renzo Corvò, Giovanni Luigi Pappagallo, Stefano Arcangeli and 2 more

Open access · goldAbstract readReview
In one paragraph

Review in Journal of breast cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 2 pooled it
0.7field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 syntheses or guidelines pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Prospective randomized clinical studies involving reirradiation: update of a systematic review.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2023
    Pooled it
  3. Pattern of practice of re-irradiation for ipsilateral breast tumor recurrence in Italy: a survey by the Italian Association of Radiotherapy and Clinical Oncology (AIRO).Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2024
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 10 institutions in 2 countries.

Marta BotteroDepartment of Radiation Oncology, Università degli Studi di Roma Tor Vergata, Rome, Italy.ORCID https://orcid.org/0000-0001-8105-2942
Valentina BorzilloRadiation Oncology Unit, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale - Napoli, Italy. v.borzillo@istitutotumori.na.it.ORCID https://orcid.org/0000-0002-6917-1735
Stefano PergolizziRadiation Oncology Unit - Department of Biomedical, Dental Science and Morphological and Functional Images, University of Messina, Messina, Italy.ORCID https://orcid.org/0000-0002-4696-7634
Barbara Alicja Jereczek-FossaDepartment of Oncology and Hemato-oncology, University of Milan, Milan, Italy.ORCID https://orcid.org/0000-0001-8151-3673
Edy IppolitoRadioterapia Oncologica, Università Campus Bio-Medico, Roma, Italy.ORCID https://orcid.org/0000-0003-1775-2009
Giovanni Piero FrezzaDepartment of Oncology, Radiation Oncology Unit, Ospedale Bellaria. Bologna, Italy.ORCID https://orcid.org/0000-0002-2332-6770
Lucio FortunatoCentro di Senologia Azienda Ospedaliera San Giovanni-Addolorata, Roma, Italy.ORCID https://orcid.org/0000-0002-8252-5833
Renzo CorvòDepartment of Radiation Oncology, National Cancer Research Institute and University, Genova, Italy.ORCID https://orcid.org/0000-0002-5001-4844
Giovanni Luigi PappagalloPrivate Epidemiologist, Silea TV, Italy.ORCID https://orcid.org/0000-0002-8247-9224
Stefano ArcangeliDepartment of Radiation Oncology, Policlinico S. Gerardo and University of Milan "Bicocca," Milan, Italy.ORCID https://orcid.org/0000-0003-3880-8876
Stefano M MagriniDepartment of Radiation Oncology, University of Brescia, Brescia, Italy.ORCID https://orcid.org/0000-0002-4126-733X
Rolando M D'AngelilloRadioterapia, Dipartimento di Biomedicina e prevenzione, Università degli Studi di Roma Tor Vergata, Roma, Italy.ORCID https://orcid.org/0000-0003-3636-6429
University of Rome Tor Vergata · ITAzienda Ospedaliera San Giovanni Addolorata · ITIstituto Nazionale Tumori IRCCS "Fondazione G. Pascale" · ITNational Cancer Research Institute · GBOspedale Bellaria · ITUniversità Campus Bio-Medico · ITUniversity of Brescia · ITUniversity of Messina · ITUniversity of Milan · ITUniversity of Milano-Bicocca · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Salvage mastectomy is currently considered the standard of care for ipsilateral breast tumor recurrence (IBTR) after breast-conserving surgery (BCS) and postoperative radiotherapy (RT). Alternative treatment options for these patients, such as a second BCS followed by repeated RT, have been suggested. The panel of the Italian Association of Radiotherapy and Clinical Oncology developed clinical recommendations for second BCS followed by re-irradiation over mastectomy alone for women with IBTR using the Grades of Recommendation, Assessment, Development, and Evaluation methodology and the evidence to decision framework. The following outcomes were identified by the panel: locoregional control, metastasis-free survival, overall survival, and cancer-specific survival; acute and late toxicity, specific late toxicity, second locoregional tumor, and death related to treatment. An Embase and PubMed literature search was performed by two independent authors. Five retrospective observational studies were eligible for inclusion in the present analysis. According to the reports in the literature and our analysis, the advantages of second quadrantectomy and re-irradiation (re-QUART) outweigh its side effects, with overall good rates of survival and adequate toxicity without increasing costs. Given the very low level of evidence, the panel stated that a second BCS plus re-irradiation can be considered as an alternative to salvage mastectomy for selected patients with IBTR.

Indexed as

Breast neoplasmsClinical practice guidelineMastectomyRadiotherapyRecurrence

Identifiers

PMID34128365
PMCPMC8250101
OpenAlexW3161579660

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.